Form 4 for TXG 10x Genomics, Inc.
Accepted 2022-11-23 00:00:00 ET · period of report 2022-11-22 · accession 0001567619-22-020871 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| M | 2022-11-23 | 2022-11-22 | TXG | Saxonov Serge | CEO, Dir | S - Sale | $34.07 | -2,676 | 974.9K | -0.3% | -$91.2K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Class A Common Stock | 2022-11-22 | S | D | 789 | $34.06 | 976,813 | D | — | — | (F1) The shares were sold to cover tax withholding obligations in connection with the vesting of restricted stock units. |
| 2 | Common | Class A Common Stock | 2022-11-22 | S | D | 1,887 | $34.07 | 974,926 | D | — | — | (F1) The shares were sold to cover tax withholding obligations in connection with the vesting of restricted stock units. |